Literature DB >> 8764053

Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles.

A Hurtado1, P Rueda, J Nowicky, J Sarraseca, J I Casal.   

Abstract

Canine parvovirus capsids are composed of 60 copies of VP2 and 6 to 10 copies of VPl. To locate essential sites of interaction between VP2 monomers, we have analyzed the effects of a number of VP2 deletion mutants representing the amino terminus and the four major loops of the surface, using as an assay the formation of virus-like particles (VLPs) expressed by recombinant baculoviruses. For the amino terminus we constructed three mutants with progressively larger deletions, i.e., 9, 14, and 24 amino acids. Deletions of 9 and 14 amino acids did not affect the morphology and assembly capabilities of the mutants. However, the mutant with the 24-amino-acid deletion did not show hemagglutination properties or correct VLP morphology, stressing again the relevance of the RNER domain in canine parvovirus functionality. Three of the four mutants with deletions in the loops failed to make correct VLPs, indicating that these regions are essential for correct capsid assembly and morphology. Only the mutant with the deletion in loop 2 was able to assemble in regular VLPs, suggesting that this loop has little or no effect in capsid morphogenesis. Further research has demonstrated that this region can tolerate the insertion of foreign epitopes that are correctly exposed in the surface of the capsid. This result opens the door to the use of these VLPs for antigen delivery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764053      PMCID: PMC190499     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  The three-dimensional structure of canine parvovirus and its functional implications.

Authors:  J Tsao; M S Chapman; M Agbandje; W Keller; K Smith; H Wu; M Luo; T J Smith; M G Rossmann; R W Compans
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

2.  A simple and rapid method for generating a deletion by PCR.

Authors:  Y Imai; Y Matsushima; T Sugimura; M Terada
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

Review 3.  Icosahedral RNA virus structure.

Authors:  M G Rossmann; J E Johnson
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

4.  Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence.

Authors:  J I Casal; J P Langeveld; E Cortés; W W Schaaper; E van Dijk; C Vela; S Kamstrup; R H Meloen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

Authors:  Y Matsuura; R D Possee; H A Overton; D H Bishop
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

6.  Hemagglutination by canine parvovirus: serologic studies and diagnostic applications.

Authors:  L E Carmichael; J C Joubert; R V Pollock
Journal:  Am J Vet Res       Date:  1980-05       Impact factor: 1.156

7.  Fine mapping of canine parvovirus B cell epitopes.

Authors:  J A López de Turiso; E Cortés; A Ranz; J García; A Sanz; C Vela; J I Casal
Journal:  J Gen Virol       Date:  1991-10       Impact factor: 3.891

8.  Nucleotide sequence and genomic organization of Aleutian mink disease parvovirus (ADV): sequence comparisons between a nonpathogenic and a pathogenic strain of ADV.

Authors:  M E Bloom; S Alexandersen; S Perryman; D Lechner; J B Wolfinbarger
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Recombinant vaccine for canine parvovirus in dogs.

Authors:  J A López de Turiso; E Cortés; C Martínez; R Ruiz de Ybáñez; I Simarro; C Vela; I Casal
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles.

Authors:  C Sedlik; J Sarraseca; P Rueda; C Leclerc; I Casal
Journal:  J Gen Virol       Date:  1995-09       Impact factor: 3.891

View more
  10 in total

1.  Parvovirus diagnostics and vaccine production in insect cells.

Authors:  J I Casal
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.

Authors:  Qunxing Pan; Kongwang He; Yongshan Wang; Xiaoli Wang; Wei Ouyang
Journal:  Virus Genes       Date:  2013-02-21       Impact factor: 2.332

3.  Study of canine parvovirus evolution: comparative analysis of full-length VP2 gene sequences from Argentina and international field strains.

Authors:  Marina Gallo Calderón; Maximiliano Wilda; Lorena Boado; Leticia Keller; Viviana Malirat; Marcela Iglesias; Nora Mattion; Jose La Torre
Journal:  Virus Genes       Date:  2011-08-20       Impact factor: 2.332

4.  Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.

Authors:  Esther Grueso; Cristina Sánchez-Martínez; Tania Calvo-López; Fernando J de Miguel; Noelia Blanco-Menéndez; Marian Fernandez-Estevez; Maria Elizalde; Jorge Sanchez; Omar Kourani; Diana Martin; Aroa Tato; Milagros Guerra; Germán Andrés; José M Almendral
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

5.  Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.

Authors:  Dolores Rodríguez; Gloria González-Aseguinolaza; Juan R Rodríguez; Aneesh Vijayan; Magdalena Gherardi; Paloma Rueda; J Ignacio Casal; Mariano Esteban
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

6.  Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles.

Authors:  Leona Gilbert; Jouni Toivola; Outi Välilehto; Taija Saloniemi; Claire Cunningham; Daniel White; Anna R Mäkelä; Eila Korhonen; Matti Vuento; Christian Oker-Blom
Journal:  J Nanobiotechnology       Date:  2006-12-08       Impact factor: 10.435

7.  Molecular characterization of canine parvovirus variants (CPV-2a, CPV-2b, and CPV-2c) based on the VP2 gene in affected domestic dogs in Ecuador.

Authors:  David De la Torre; Eulalia Mafla; Byron Puga; Linda Erazo; Claudete Astolfi-Ferreira; Antonio Piantino Ferreira
Journal:  Vet World       Date:  2018-04-16

Review 8.  Virus-like particles: models for assembly studies and foreign epitope carriers.

Authors:  Andrzej Palucha; Adrianna Loniewska; Subbian Satheshkumar; Anna M Boguszewska-Chachulska; Mahadevaiah Umashankar; Malgorzata Milner; Anne-Lise Haenni; Handanahal Subbarao Savithri
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

9.  Magnetic Resonance Imaging Revealed Splenic Targeting of Canine Parvovirus Capsid Protein VP2.

Authors:  Yufei Ma; Haiming Wang; Dan Yan; Yanquan Wei; Yuhua Cao; Peiwei Yi; Hailu Zhang; Zongwu Deng; Jianwu Dai; Xiangtao Liu; Jianxun Luo; Zhijun Zhang; Shiqi Sun; Huichen Guo
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

10.  CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults.

Authors:  Juha Lindner; Sandra Zehentmeier; Rauli Franssila; Sascha Barabas; Josef Schroeder; Ludwig Deml; Susanne Modrow
Journal:  J Infect Dis       Date:  2008-12-01       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.